Page 2183 - Markets News

Chris Wood bullish on cyclical stocks; sees more stimulus from US Fed

GREED & fear's view is that there is a scope for US Fed action inter-meeting if the market action is violent enough

Sales of MF products from B30 cities remain stagnant in the past 2 years

Restriction in physical movement of distributors due to the pandemic may further impact numbers

Passive funds dominate NFO line up as most active fund lag benchmarks

Fund houses have launched ETFs in both equity and debt segments

Sebi fines Rana Kapoor Rs 1 cr for hiding a transaction from YES board

By not disclosing about the transaction to Yes Bank's board of directors, Kapoor has created an opaque layer between him and stakeholders, Sebi said in an order.

Investors richer by Rs 3.52 trillion as markets make strong comeback

Snapping its six-day falling streak, the BSE benchmark index jumped 835.06 points or 2.28 per cent to close at 37,388.66

Market Wrap, Sept 25: Here's all that happened in the markets today

On a weekly basis, both Sensex and Nifty declined nearly 4 per cent

MARKET WRAP: Sensex surges 835 pts, Nifty reclaims 11K; Nifty IT up over 3%

All that happened in the markets today

Vakrangee hits 10% upper circuit on RBI's in-principle nod to set up BBPOU

Despite the 10 per cent surge on Friday, the stock has underperformed the market by falling 19 per cent in past three months, as against 7 per cent rally in the S&P BSE Sensex

Camlin Fine surges 11% in one week after it starts production at Dahej unit

The company will produce Hydroquinone and Catechol, key raw materials for the business, at the lowest cost in the world at the Dahej facility, which shall benefit margins

Financial sector is in the middle of a perfect storm: Pankaj Murarka

"September quarter earnings will be somewhat a mixed bag, as the pandemic has had varying impact on companies across sectors," says Murarka.

Cipla surges 5% on USFDA approval for dimethyl fumarate DR capsules

The drug, indicated for treatment of relapsing forms of multiple sclerosis, had annual US sales of US$3.8 billion as per IQVIA MAT July 2020.

Granules India up 5% on USFDA approval for generic Aleve PM tablets

According to media reports, global private equity firms have expressed interest in acquiring a controlling stake in the company

Bharti Airtel gains 5% after falling 11% in 2 trading sessions

A lack of tariff hike visibility in the near term, success of Jio's renewed post-paid push, delayed reaction from Bharti to counter Jio will determine Airtel's stock performance, say analysts

Accenture Q4FY20 earnings: Five key takeaways for the Indian IT companies

Analysts at Nomura note that Accenture's weakness is restricted to stressed verticals such as retail, manufacturing, travel, and energy, which contributed nearly 20 per cent of revenues.

Prince Pipes hits highest level since listing; stock zooms 242% in 4 months

The stock rallied 8% in the intra-day trade on Friday to Rs 260, its highest level since its listing on December 30, 2019

GMR Infrastructure gains 4% on stake sale in Kakinada SEZ

The company has signed definitive agreements for the sale of equity owned by its wholly owned subsidiary GMR SEZ and Port Holding of its entire 51 per cent stake in Kakinada SEZ to Aurobindo Realty

Advanced Enzyme Technologies soars 30% in 2 days after FPI picks 4% stake

On Thursday, Nalanda India Equity Fund bought 4.19 million equity shares, representing 3.75 per cent stake, in Advanced Enzyme for Rs 111 crore

Stocks to watch: IT stks, Cipla, RIL, TCS, Tata Coffee, Mahindra & Mahindra

Here's a list of stocks that may trade actively in today's session

Market Ahead, September 25: Top factors that could guide markets today

Banks will be a key focus in today's session after the central government extended the suspension on initiating insolvency and bankruptcy proceedings against firms for three more months

Investment in IndusInd Bank stocks a value bet, but tread with caution

Trading below its book value (0.9x its FY22 estimated earnings), analysts at Nomura, UBS, and CLSA are positive, primarily for its beaten-down valuation.